Literature DB >> 18435963

Comparison of outcomes in high-risk patients>70 years of age with aortic valvuloplasty and percutaneous coronary intervention versus aortic valvuloplasty alone.

Wes R Pedersen1, Paul J Klaassen, Christopher W Pedersen, Jessica A Wilson, Kevin M Harris, Irvin F Goldenberg, Anil K Poulose, Michael R Mooney, Timothy D Henry, Robert S Schwartz.   

Abstract

The goal of this study was to compare outcomes of combined balloon aortic valvuloplasty (BAV) plus percutaneous coronary intervention (PCI) with BAV alone in a surgically high risk, older (>70 years) population with both aortic stenosis (AS) and coronary artery disease (CAD). The medical records, coronary angiograms, and procedural reports of 100 consecutive patients who underwent BAV and coronary angiography at our institution from July 2003 to November 2006 were reviewed. Seventeen patients (mean age 86.2+/-6.4 years) underwent combined (nonstaged) BAV and PCI with a calculated Society of Thoracic Surgery risk score of 13.5%+/-6.7; 13 of these underwent coronary stenting before BAV and 4 after BAV. All 17 patients were successfully treated with this combined strategy. The incidence of periprocedural mortality, myocardial infarction, and stroke was zero. An additional 25 patients (mean age 85.9+/-6.9) with CAD were identified who underwent BAV alone with a Society of Thoracic Surgery risk score of 12.6+/-5.7%. PCI in these patients was avoided primarily because of greater lesion complexity or a perceived low probability of symptomatic benefit. There was 1 procedural death, no myocardial infarction, and 1 postprocedural stroke in these 25 patients. The procedural duration and hospital length of stay for the combined BAV and PCI group was 98.8+/-17.6 minutes and 4.1+/-2.8 days, respectively, and for the BAV only group was 86.2+/-27.3 minutes and 3.3+/-2.1 days, respectively. In conclusion, with appropriate selection, BAV plus PCI was safely performed in this retrospective series of elderly, high-risk patients with severe AS and CAD.

Entities:  

Mesh:

Year:  2008        PMID: 18435963     DOI: 10.1016/j.amjcard.2007.12.033

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention.

Authors:  Lenard Conradi; Moritz Seiffert; Olaf Franzen; Stephan Baldus; Johannes Schirmer; Thomas Meinertz; Hermann Reichenspurner; Hendrik Treede
Journal:  Clin Res Cardiol       Date:  2010-10-21       Impact factor: 5.460

2.  Palliative combined percutaneous balloon aortic valvuloplasty and unprotected left main stenting in end stage renal disease.

Authors:  Todd A Dorfman; Raed Aqel
Journal:  Curr Cardiol Rev       Date:  2010-02

3.  Patients with small left ventricular size undergoing balloon aortic valvuloplasty have worse intraprocedural outcomes.

Authors:  Creighton Don; Pritha P Gupta; Christian Witzke; Manoj Kesarwani; Roberto J Cubeddu; Ignacio Inglessis; Igor F Palacios
Journal:  Catheter Cardiovasc Interv       Date:  2012-08-23       Impact factor: 2.692

4.  Efficacy and safety of percutaneous transcatheter aortic valvuloplasty prior to non-cardiac surgery in Japanese patients with severe aortic stenosis.

Authors:  Hiroya Takafuji; Shinobu Hosokawa; Riyo Ogura; Yoshikazu Hiasa
Journal:  Cardiovasc Interv Ther       Date:  2019-03-07

5.  Balloon aortic valvuloplasty (BAV) as a bridge to aortic valve replacement in cancer patients who require urgent non-cardiac surgery.

Authors:  Polonca Kogoj; Rok Devjak; Matjaz Bunc
Journal:  Radiol Oncol       Date:  2014-01-22       Impact factor: 2.991

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.